Preclinical studies, like the one performed by Kageyama et al. [10], have shown that targeting USP8 with specific inhibitors can suppress ACTH production, reduce tumor cell proliferation, and induce apoptosis in corticotroph tumor models. Here, USP8 is linked to neoplasm.